TLR3 agonists as immunotherapeutic agents
CF Nicodemus, JS Berek - Immunotherapy, 2010 - Taylor & Francis
The interaction of innate and adaptive immune responses is extremely complex and just
beginning to be understood in detail. The tendency for biomedical research to establish …
beginning to be understood in detail. The tendency for biomedical research to establish …
[引用][C] TLR3 agonists as immunotherapeutic agents.
CF Nicodemus, JS Berek - Immunotherapy, 2010 - europepmc.org
TLR3 agonists as immunotherapeutic agents. - Abstract - Europe PMC Sign in | Create an
account https://orcid.org Europe PMC Menu About Tools Developers Help Contact us Helpdesk …
account https://orcid.org Europe PMC Menu About Tools Developers Help Contact us Helpdesk …
TLR3 agonists as immunotherapeutic agents
CF Nicodemus, JS Berek - Immunotherapy, 2010 - search.proquest.com
The interaction of innate and adaptive immune responses is extremely complex and just
beginning to be understood in detail. The tendency for biomedical research to establish …
beginning to be understood in detail. The tendency for biomedical research to establish …
TLR3 agonists as immunotherapeutic agents
CF Nicodemus, JS Berek - Immunotherapy, 2010 - go.gale.com
The interaction of innate and adaptive immune responses is extremely complex and just
beginning to be understood in detail. The tendency for biomedical research to establish …
beginning to be understood in detail. The tendency for biomedical research to establish …
[引用][C] TLR3 agonists as immunotherapeutic agents
CF Nicodemus, JS Berek - Immunotherapy, 2010 - pubmed.ncbi.nlm.nih.gov
TLR3 agonists as immunotherapeutic agents TLR3 agonists as immunotherapeutic agents
Immunotherapy. 2010 Mar;2(2):137-40. doi: 10.2217/imt.10.8. Authors Christopher F …
Immunotherapy. 2010 Mar;2(2):137-40. doi: 10.2217/imt.10.8. Authors Christopher F …